2012 glutathione alzheimer's disease five authors in the Brain Inducing Agents for Alzheimer's Disease

The new 5-HT hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression

The top pick for self-injection

Its ability to accelerate gut healing, decrease inflammation, regulate gut motility, and support a balanced gut microbiota highlights its value as a therapeutic peptide for both digestive function and health

US Patent

Proteins predicted to interact with Glutathione Synthetase Predicted protein interactions based upon String database